148 related articles for article (PubMed ID: 24817712)
21. Inhibition of InhA, the enoyl reductase from Mycobacterium tuberculosis, by triclosan and isoniazid.
Parikh SL; Xiao G; Tonge PJ
Biochemistry; 2000 Jul; 39(26):7645-50. PubMed ID: 10869170
[TBL] [Abstract][Full Text] [Related]
22. Aldo-keto reductase (AKR) superfamily: genomics and annotation.
Mindnich RD; Penning TM
Hum Genomics; 2009 Jul; 3(4):362-70. PubMed ID: 19706366
[TBL] [Abstract][Full Text] [Related]
23. Drug resistance in Mycobacterium tuberculosis and targeting the l,d-transpeptidase enzyme.
Gokulan K; Varughese KI
Drug Dev Res; 2019 Feb; 80(1):11-18. PubMed ID: 30312987
[TBL] [Abstract][Full Text] [Related]
24. Purification, molecular cloning, and catalytic activity of Schizosaccharomyces pombe pyridoxal reductase. A possible additional family in the aldo-keto reductase superfamily.
Nakano M; Morita T; Yamamoto T; Sano H; Ashiuchi M; Masui R; Kuramitsu S; Yagi T
J Biol Chem; 1999 Aug; 274(33):23185-90. PubMed ID: 10438489
[TBL] [Abstract][Full Text] [Related]
25. Comparative analysis of mycobacterial NADH pyrophosphatase isoforms reveals a novel mechanism for isoniazid and ethionamide inactivation.
Wang XD; Gu J; Wang T; Bi LJ; Zhang ZP; Cui ZQ; Wei HP; Deng JY; Zhang XE
Mol Microbiol; 2011 Dec; 82(6):1375-91. PubMed ID: 22026918
[TBL] [Abstract][Full Text] [Related]
26. The mabA gene from the inhA operon of Mycobacterium tuberculosis encodes a 3-ketoacyl reductase that fails to confer isoniazid resistance.
Banerjee A; Sugantino M; Sacchettini JC; Jacobs WR
Microbiology (Reading); 1998 Oct; 144 ( Pt 10)():2697-2704. PubMed ID: 9802011
[TBL] [Abstract][Full Text] [Related]
27. A new nomenclature for the aldo-keto reductase superfamily.
Jez JM; Flynn TG; Penning TM
Biochem Pharmacol; 1997 Sep; 54(6):639-47. PubMed ID: 9310340
[TBL] [Abstract][Full Text] [Related]
28. Cloning and characterization of arylamine N-acetyltransferase genes from Mycobacterium smegmatis and Mycobacterium tuberculosis: increased expression results in isoniazid resistance.
Payton M; Auty R; Delgoda R; Everett M; Sim E
J Bacteriol; 1999 Feb; 181(4):1343-7. PubMed ID: 9973365
[TBL] [Abstract][Full Text] [Related]
29. In vitro inhibition of the Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein reductase MabA by isoniazid.
Ducasse-Cabanot S; Cohen-Gonsaud M; Marrakchi H; Nguyen M; Zerbib D; Bernadou J; Daffé M; Labesse G; Quémard A
Antimicrob Agents Chemother; 2004 Jan; 48(1):242-9. PubMed ID: 14693546
[TBL] [Abstract][Full Text] [Related]
30. Reduced affinity for Isoniazid in the S315T mutant of Mycobacterium tuberculosis KatG is a key factor in antibiotic resistance.
Yu S; Girotto S; Lee C; Magliozzo RS
J Biol Chem; 2003 Apr; 278(17):14769-75. PubMed ID: 12586821
[TBL] [Abstract][Full Text] [Related]
31. Methylglyoxal detoxification by an aldo-keto reductase in the cyanobacterium Synechococcus sp. PCC 7002.
Xu D; Liu X; Guo C; Zhao J
Microbiology (Reading); 2006 Jul; 152(Pt 7):2013-2021. PubMed ID: 16804176
[TBL] [Abstract][Full Text] [Related]
32. The Effects Study of Isoniazid Conjugated Multi-Wall Carbon Nanotubes Nanofluid on
Zomorodbakhsh S; Abbasian Y; Naghinejad M; Sheikhpour M
Int J Nanomedicine; 2020; 15():5901-5909. PubMed ID: 32884258
[TBL] [Abstract][Full Text] [Related]
33. Mutation of katG in a clinical isolate of Mycobacterium tuberculosis: effects on catalase-peroxidase for isoniazid activation.
Purkan ; Ihsanawati ; Natalia D; Syah YM; Retnoningrum DS; Kusuma HS
Ukr Biochem J; 2016; 88(5):71-81. PubMed ID: 29235814
[TBL] [Abstract][Full Text] [Related]
34. Comparative anatomy of the aldo-keto reductase superfamily.
Jez JM; Bennett MJ; Schlegel BP; Lewis M; Penning TM
Biochem J; 1997 Sep; 326 ( Pt 3)(Pt 3):625-36. PubMed ID: 9307009
[TBL] [Abstract][Full Text] [Related]
35. The crystal structure of rat liver AKR7A1. A dimeric member of the aldo-keto reductase superfamily.
Kozma E; Brown E; Ellis EM; Lapthorn AJ
J Biol Chem; 2002 May; 277(18):16285-93. PubMed ID: 11839745
[TBL] [Abstract][Full Text] [Related]
36. Modeling the structural origins of drug resistance to isoniazid via key mutations in Mycobacterium tuberculosis catalase-peroxidase, KatG.
Marney MW; Metzger RP; Hecht D; Valafar F
Tuberculosis (Edinb); 2018 Jan; 108():155-162. PubMed ID: 29523317
[TBL] [Abstract][Full Text] [Related]
37. [Comparison of the proteomes of isoniazid-resistant Mycobacterium tuberculosis strains and isoniazid-susceptible strains].
Jiang X; Gao F; Zhang WH; Hu ZY; Wang HH
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):427-31. PubMed ID: 17673015
[TBL] [Abstract][Full Text] [Related]
38. Characterization of the catalase-peroxidase gene (katG) and inhA locus in isoniazid-resistant and -susceptible strains of Mycobacterium tuberculosis by automated DNA sequencing: restricted array of mutations associated with drug resistance.
Musser JM; Kapur V; Williams DL; Kreiswirth BN; van Soolingen D; van Embden JD
J Infect Dis; 1996 Jan; 173(1):196-202. PubMed ID: 8537659
[TBL] [Abstract][Full Text] [Related]
39. Glyoxal detoxification in Escherichia coli K-12 by NADPH dependent aldo-keto reductases.
Lee C; Kim I; Park C
J Microbiol; 2013 Aug; 51(4):527-30. PubMed ID: 23990306
[TBL] [Abstract][Full Text] [Related]
40. Synthesis, characterization and in-vitro antitubercular activity of isoniazid-gelatin conjugate.
Cassano R; Trombino S; Ferrarelli T; Cavalcanti P; Giraldi C; Lai F; Loy G; Picci N
J Pharm Pharmacol; 2012 May; 64(5):712-8. PubMed ID: 22471367
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
